{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260809993728/en/Silence-Therapeutics-to-Host-Conference-Call-and-Webcast-to-Discuss-Topline-Results-from-Phase-2-SANRECO-Trial-of-Divesiran-in-Polycythemia-Vera", "message": "News view counter 871516 successfully enlarged"}